Contributor: John Zhao
Collagenase clostridium histolyticum (CCH) injections were FDA approved in 2010 for use in Dupuytren’s contracture. Interest among surgeons in this office-based treatment has rapidly increased in the past 5 years due to its shorter recovery time and limited complication rates compared to open fasciectomy.
DOI: http://dx.doi.org/10.17797/qps5cwzfgu
Editor Recruited By: David Bozentka, MD
Sign up for our free membership to watch and submit videos today! If you are already a member please log in to access your account.
Sign Up NowAlready a member? Click here to log in
Sign up for our free membership to watch and submit videos today! If you are already a member please log in to access your account.
Sign Up NowAlready a member? Click here to log in
Please upgrade to membership to continue watching more videos.
Upgrade NowPlease renew your subscription to continue watching.
Renew Now